NASDAQ:TNXP
Tonix Pharmaceuticals Stock News
$1.15
+0.0600 (+5.50%)
At Close: Jun 14, 2024
Tonix Pharmaceuticals Holdings Corp. Prices $40M Common Stock Offering Priced at-the-Market Under Nasdaq Rules
12:59pm, Monday, 11'th Jan 2021
CHATHAM, N.J., Jan. 11, 2021 (GLOBE NEWSWIRE) -- TONIX PHARMACEUTICALS HOLDINGS CORP. (NASDAQ: TNXP) (“Tonix” or the “Company”), a clinical-stage biopharmaceutical company, today announced i
Tonix Pharmaceuticals to Participate in Upcoming January Conferences
04:15pm, Tuesday, 05'th Jan 2021
CHATHAM, N.J., Jan. 05, 2021 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, announced today that Seth Lederm
Tonix Pharmaceuticals Plans Commercial Scale Vaccine Manufacturing Facility
09:00am, Wednesday, 23'rd Dec 2020
Hamilton, MT Facility Is Planned to Manufacture Vaccines at Commercial Scale, Including Vaccines Under Development for COVID-19
University of Geneva Technology Covers Broad Applications for Cardiometabolic Syndromes University of Geneva Technology Covers Broad Applications for Cardiometabolic Syndromes
Tonix Pharmaceuticals News: TNXP Stock Soars on Fibromyalgia Drug Results
10:21am, Monday, 07'th Dec 2020
Tonix Pharmaceuticals (TNXP) news for Monday includes results from a recent Phase 3 clinical trial boosting TNXP stock higher. The post Tonix Pharmaceuticals News: TNXP Stock Soars on Fibromyalgia Dru
Covid-19 Is Not Going to Go Away: Tonix Pharmaceuticals CEO
12:30am, Monday, 07'th Dec 2020
Dec.06 -- Seth Lederman, chairman and chief executive officer of Tonix Pharmaceuticals, talks about the coronavirus outbreak and the rollout of vaccines. Tonix has two Covid-19 vaccine in the pipeline
Anti-SARS-CoV-2 Neutralizing Antibodies Elicited in All Eight TNX-1800 Vaccinated Animals
Increasing Placebo Responses in PTSD Drug Trials Raise Questions About Current Methods of Measuring or Analyzing PTSD Symptom Change Over Time
7 Biotech Penny Stocks Worth a Gamble
11:50am, Wednesday, 11'th Nov 2020
With the pandemic drawing much attention toward biotech stocks, there are some interesting ideas among in the small-cap field, but only if you understand the severe risks involved. The post 7 Biotech
Tonix Pharmaceuticals to Participate in Upcoming November Conferences
07:00am, Wednesday, 11'th Nov 2020
CHATHAM, N.J., Nov. 11, 2020 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, announced today that Seth Lederm
Tonix Pharmaceuticals to Present at 3rd Annual Neuropsychiatric Drug Development Summit
04:15pm, Monday, 09'th Nov 2020
CHATHAM, N.J., Nov. 09, 2020 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, announced today that Seth Lederm
Tonix Pharmaceuticals Reports Third Quarter 2020 Financial Results and Operational Highlights
08:30am, Monday, 09'th Nov 2020
Data from Animal Studies of COVID-19 Vaccine Candidate, TNX-1800, Expected in Fourth Quarter 2020
